Thromboembolic therapies in dogs and cats: an evidence-based approach.
In veterinary medicine, we are forced to make use of less than ideal "evidence," such as extrapolation from experimental studies in dogs and cats without naturally occurring diseases and from clinical trials in other species (particularly human clinical trials), as well as limited information gained from veterinary clinical experience, small clinical trials, case studies, and anecdotal reports. In this article, specific treatment recommendations are made for each of the common thromboembolic conditions seen in dogs and cats. These recommendations are made with the important caveat that, to date, such suggested therapeutic approaches are based on limited evidence.
Lunsford
Kari V
KV
Department of Clinical Sciences, College of Veterinary Medicine, Mail Stop 9825, Spring Street, Mississippi State University, Mississippi State, MS 39762-6100, USA. lunsford@cvm.msstate.edu
Mackin
Andrew J
AJ
D000818:Animals; D002371:Cat Diseases / Q000517:prevention & control / Q000628:therapy*; D002415:Cats; D004283:Dog Diseases / Q000517:prevention & control / Q000628:therapy*; D004285:Dogs; D004621:Embolization, Therapeutic / Q000379:methods / Q000662:veterinary*; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D013045:Species Specificity; D013923:Thromboembolism / Q000517:prevention & control / Q000628:therapy / Q000662:veterinary*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D006493:Heparin